MG
ZYME icon

Michael Gelband’s Zymeworks ZYME Stock Holding History

Michael Gelband’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,374
Closed -$685K – 2158
2026
Q1 		$685K Buy
+27,374
New +$648K 0.01% 1106
2025
Q3 		– Sell
-51,669
Closed -$648K – 2098
2025
Q2 		$648K Sell
51,669
-81,651
-61% -$973K 0.01% 1077
2025
Q1 		$1.59M Buy
+133,320
New +$1.82M 0.02% 779
2024
Q1 		– Sell
-18,006
Closed -$187K – 2036
2023
Q4 		$187K Buy
+18,006
New +$143K ﹤0.01% 1290
2023
Q2 		– Sell
-43,731
Closed -$395K – 2314
2023
Q1 		$395K Buy
+43,731
New +$381K ﹤0.01% 1400
2022
Q4 		– Sell
-11,079
Closed -$68K – 2218
2022
Q3 		$68K Buy
+11,079
New +$66.8K ﹤0.01% 1781
2022
Q2 		– Sell
-16,599
Closed -$109K – 2537
2022
Q1 		$109K Sell
16,599
-38,573
-70% -$344K ﹤0.01% 1995
2021
Q4 		$904K Buy
55,172
+11,047
+25% +$230K 0.01% 1128
2021
Q3 		$1.28M Buy
+44,125
New +$1.47M 0.02% 917
2021
Q2 		– Sell
-16,798
Closed -$530K – 2883
2021
Q1 		$530K Buy
16,798
+1,806
+12% +$73.4K 0.01% 1308
2020
Q4 		$709K Buy
+14,992
New +$696K 0.01% 1044
2020
Q3 		– Sell
-27,067
Closed -$976K – 2297
2020
Q2 		$976K Buy
+27,067
New +$997K 0.03% 756

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Michael Gelband's ZYME Position: Q2 2026 in Review

Michael Gelband sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 27,374 shares — an estimated $685K sold.

Michael Gelband first reported a position in ZYME in Q2 2020 and held it in 12 quarters. The position peaked at $1.59M in Q1 2025. 201 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Michael Gelband reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 27,374 Zymeworks shares in Q2 2026, an estimated $685K.
  • Michael Gelband first reported a position in Zymeworks in Q2 2020 and held it in 12 quarters.
  • Michael Gelband's Zymeworks position peaked at $1.59M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.